Kura Oncology, Inc.

Historical 13F Holders

Symbol
KURA
CUSIP
50127T109
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 191 80.5 M $531 M
2024 Q4 192 78.8 M $686 M
2024 Q3 188 82.9 M $1.62 B
2024 Q2 187 82.2 M $1.69 B
2024 Q1 180 83.9 M $1.79 B
2023 Q4 148 81.1 M $1.17 B
2023 Q3 138 75.3 M $687 M
2023 Q2 157 75.1 M $795 M
2023 Q1 148 72.7 M $888 M
2022 Q4 153 74.6 M $926 M
2022 Q3 160 72.5 M $990 M
2022 Q2 160 69.0 M $1.27 B
2022 Q1 161 67.1 M $1.12 B
2021 Q4 169 64.4 M $902 M
2021 Q3 162 66.7 M $1.25 B
2021 Q2 182 67.8 M $1.41 B
2021 Q1 180 68.6 M $1.94 B
2020 Q4 220 65.8 M $2.15 B
2020 Q3 174 53.8 M $1.65 B
2020 Q2 142 52.8 M $861 M
2020 Q1 124 42.8 M $424 M
2019 Q4 132 39.6 M $544 M
2019 Q3 118 40.2 M $610 M
2019 Q2 127 38.9 M $765 M
2019 Q1 110 32.4 M $536 M
2018 Q4 101 32.8 M $460 M
2018 Q3 123 30.4 M $532 M
2018 Q2 112 29.8 M $542 M
2018 Q1 99 23.7 M $444 M
2017 Q4 76 19.5 M $299 M
2017 Q3 67 19.5 M $292 M
2017 Q2 44 10.8 M $101 M
2017 Q1 36 10.7 M $94.5 M
2016 Q4 31 10.0 M $59.2 M
2016 Q3 28 9.75 M $60.9 M
2016 Q2 25 9.32 M $25.2 M
2016 Q1 20 10.2 M $41.4 M
2015 Q4 14 10.2 M $86.1 M